Quote For Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD.O) (Nasdaq)
sector: Healthcare ·
industry: Biotechnology ·
$46.96
24 Nov 2009
-0.11%
$47.01
$47.13
4,359,893
$47.37
$46.57
$53.28
$40.62
0.50
5,661,335
News
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Martin, John | Chairman of the Board, Chief Executive Officer | 10,998,006 |
| Milligan, John | President, Chief Operating Officer | 5,187,437 |
| Washington, Robin | Chief Financial Officer, Senior Vice President | 1,166,870 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $42,305.48 |
| Shares Outstanding (Mil.) | 899.92 |
| Float (Mil.) | 895.30 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 2.76 |
| Current Ratio | 2.27 |
| LT Debt/Equity | 20.21 |
| Total Debt/Equity | 23.85 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 18.36 |
| Price/Sales(TTM) | 6.60 |
| Price/Book(TTM) | 7.51 |
| Price/Cash Flow(TTM) | 16.46 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $2.65 |
| Sales(TTM) | $6.83 |
| Book Value(MRQ) | $6.26 |
| Cash Flow(TTM) | $2.74 |
| Cash(MRQ) | $1.50 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 48.95 |
| Return on Assets(TTM) | 30.10 |
| Return on Investment(TTM) | 38.22 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 77.47 |
| Operating Margin(TTM) % | 49.55 |
| Profit Margin(TTM) % | 37.37 |
Commodities
| Commodity | Last | Pct Chg | Trade Date/Time |
|---|---|---|---|
| Oil | 76.71 | +0.33% | 11/25 10:02 IST |
| Gold | 1176.6 | +0.92% | 11/25 09:42 IST |
